The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia

AIDS

Volumn 21, Issue 18, 2007, Pages 2417-2424

  Laderoute, Marian P ^a,b   Giulivi, Antonio ^a,b   Larocque, Louise ^a   Bellfoy, Deana ^a   Hou, Yangxun ^a   Wu, Hong Xing ^a   Fowke, Keith ^c   Wu, Jun ^a   Diaz Mitoma, Francisco ^d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

HERV K102; HIV 1 host factors; Plasma; QPCR; Replication; Serology

Indexed keywords

COMPLEMENTARY DNA; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA TEMPLATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROVIRUS; SEROLOGY; VIRUS ACTIVATION; VIRUS ENVELOPE; VIRUS REPLICATION;

DNA, COMPLEMENTARY; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; TEMPLATES, GENETIC; VIREMIA; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 36348933949     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f14d64     Document Type: Article

References (42)

1. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Med USA 2004; 101 (Suppl 2):14572-14579.
2. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 5:179-211.
3. Benit L, Dessen P, Heidmann T. Identification, phylogeny and evolution of retroviral elements based on their envelope genes. J Virol 2001; 75:11709-11719.
4. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, et al. Long term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA 2004; 101:4894-4899.
5. Belshaw R, Dawson ALA, Woolven-Allen J, Redding J, Burt A, Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K (HML2): implications for present day activity. J Virol 2005; 79:12507-12514.
6. Ono M. Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol 1986; 58:937-944.
7. Barbulescu M, Turner G, Seaman MI, Dienard AS, Kidd KK, Lenz J. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol 1999; 9:861-868.
8. Muster T, Waltenberger A, Grassauer A, Hirschi S, Caucig P, Romirer I, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003; 63:8735-8741.
9. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, et al. Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin Cancer Res 2001; 7:1553-1560.
10. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003; 22:528-535.
11. Simpson GR, Patience C, Lower R, Tonjes RR, Moore HD, Weiss RA, et al. Endogenous D-Type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcription. Virology 1996; 222:451-456.
12. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 2005; 65:4172-4180.
13. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 1993; 90:4480-4484.
14. Bieda K, Hoffmann A, Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 2001; 82:591-596.
15. Patience C, Simpson GR, Colletta AA, Welch HM, Weiss RA, Boyd MT. Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J Virol 1996; 70:2654-2657.
16. Tonjes RR, Boller K, Limbach C, Lugert R, Kurth R. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology 1997; 222:451-456.
17. Dewannieux M, Harper F, Richaud A. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res 2006; 16:1548-1556.
18. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997; 71:4581-4588.
19. Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulandin S, et al. HERV-K (HML-2) Gag/Env antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer 2004; 110:459-461.
20. Goedert JJ, Sauter ME, Jacobson LP, Vessella RL, Hilgartner MW, Leitman SF, et al. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS. Cancer Epidemiol Biomarkers Prevent 1999; 8:293-296.
21. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retroviral sequences. Proc Natl Acad Sci USA 1996; 93:5177-5184.
22. Vogetseder W, Dumtahrt A, Mayersbach P, Schonitzer D, Dierich MP. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. AIDS Res Hum Retroviruses 1993; 9:687-694.
23. Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, et al. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clinical Cancer Res 2002; 8:1800-1807.
24. Sugimoto J, Matsuura N, Kinjo Y, Takasu N, Oda T, Jinno Y. Transcriptionally active HERV-K genes: identification, isolation and chromosomal mapping. Genomics 2001; 72:137-144.
25. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immunol 2004; 4:2-19.
26. Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, et al. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol 2005; 79:341-352.
27. Johnston JB, Siva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001; 50:434-442.
28. Contreras-Galindo R, Gonzalez M, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART nonsuppressive regimens. J Virol Meth 2006; 136:51-57.
29. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. Detection of HERV-K (HML-2) viral RNA in plasma of HIV Type 1-infected individuals. AIDS Res Hum Retroviruses 2006; 22:979-984.
30. Chen R, Wang H, Mansky LM. Roles of uracil-DNA glycosylase and dUTPase in virus replication. J Gen Virol 2002; 83:2339-2345.
31. Priet S, Sire J, Querat G. Uracils as a cellular weapon against viruses and mechanisms of viral escape. Curr HIV Res 2006; 4:31-42.
32. Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J Virol 1999; 73:1565-1572.
33. Linial ML. Foamy viruses are unconventional retroviruses. J Virol 1999; 73:1747-1755.
34. Delelis O, Lehmann-Che J, Saib A. Foamy viruses - a world apart. Curr Opin Microbiol 2004; 7:400-406.
35. Sutkowski N, Chen G, Calderon G, Huber BT. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for trans-activation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 2004; 78:7852-7260.
36. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 2004; 18:101-106.
37. Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, Sumpter TR, et al. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease? Biochemistry 1998; 37:17137-17144.
38. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 2007; 23:116-122.
39. Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, et al. Mechanisms of gastrointestinal CD4R T-cell depletion during acute and early human immunodeficiency virus type I infection. J Virol 2007; 81:599-612.
40. Brooks JI, Merks HW, Fournier J, Boneva RS, Sandstrom PA. Characterization of blood-borne transmission of simian foamy virus. Transfusion 2007; 47:162-170.
41. Padow M, Lai L, Fisher RJ, Zhou YC, Wu X, Kappes JC, et al. Analysis of human immunodeficiency virus type I containing HERV-K protease. AIDS Res Human Retroviruses 2000; 16: 1973-1980.
42. Kuhelj R, Rizzo CJ, Chang CH, Jadhav PK, Towler EM, Korant BD. Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays. J Biol Chem 2001; 276: 16674-16682.